Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activation.
about
Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cellsBrk activates rac1 and promotes cell migration and invasion by phosphorylating paxillinBidirectional signals transduced by DAPK-ERK interaction promote the apoptotic effect of DAPKEtk/Bmx as a tumor necrosis factor receptor type 2-specific kinase: role in endothelial cell migration and angiogenesisDAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signalsNeuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinaseThe role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption.CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitorsPhosphorylation of tyrosine 285 of PAK1 facilitates βPIX/GIT1 binding and adhesion turnoverProtein-tyrosine phosphatase D1, a potential regulator and effector for Tec family kinasesThe Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent mannerThe role of tyrosine kinase Etk/Bmx in EGF-induced apoptosis of MDA-MB-468 breast cancer cellsInteraction between tyrosine kinase Etk and a RUN domain- and FYVE domain-containing protein RUFY1. A possible role of ETK in regulation of vesicle traffickingEtk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathwayEtk/Bmx regulates proteinase-activated-receptor1 (PAR1) in breast cancer invasion: signaling partners, hierarchy and physiological significanceTyrosine kinase ETK/BMX is up-regulated in bladder cancer and predicts poor prognosis in patients with cystectomyTranscription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells.The tumor suppressor DAPK inhibits cell motility by blocking the integrin-mediated polarity pathway.Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitorMolecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs.MicroRNAs in the Myocyte Enhancer Factor 2 (MEF2)-regulated Gtl2-Dio3 Noncoding RNA Locus Promote Cardiomyocyte Proliferation by Targeting the Transcriptional Coactivator Cited2.A novel BMX variant promotes tumor cell growth and migration in lung adenocarcinoma.The Tec family of cytoplasmic tyrosine kinases: mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other species.Src inhibitors: genomics to therapeutics.Par genes: molecular probes to pathological assessment in breast cancer progressionTyrosine kinase BMX phosphorylates phosphotyrosine-primed motif mediating the activation of multiple receptor tyrosine kinasesSrc family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530.Critical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesisEssential role of Stat3 in PI3K-induced oncogenic transformationBMX Negatively Regulates BAK Function, Thereby Increasing Apoptotic Resistance to Chemotherapeutic Drugsδ-tocotrienol induces human bladder cancer cell growth arrest, apoptosis and chemosensitization through inhibition of STAT3 pathway.Novel perspective: focusing on the X chromosome in reproductive cancers.STAT3 activation in pressure-overloaded feline myocardium: role for integrins and the tyrosine kinase BMXLNCaP prostate cancer cells with autocrine interleukin-6 expression are resistant to IL-6-induced neuroendocrine differentiation due to increased expression of suppressors of cytokine signalingFunctional role and therapeutic potential of the pim-1 kinase in colon carcinoma.Focal adhesion kinase: a promising target for anticancer therapy.A point mutation, E95D, in the mumps virus V protein disengages STAT3 targeting from STAT1 targeting.Current understanding of tyrosine kinase BMX in inflammation and its inhibitors.The expression and role of tyrosine kinase ETK/BMX in renal cell carcinomaTargeting tyrosine kinases and autophagy in prostate cancer.
P2860
Q24302022-343DC668-F39A-41C5-B5C4-C7EDB1A8E6DCQ24318315-3A3B3128-2250-419D-B63D-AB0FC761D0E5Q24336428-F16AA761-26EB-455F-834F-17B3755A725BQ24540207-1BAE296E-07D1-433E-81CA-463C1651A776Q24672929-90FEA19B-BC9A-46F7-A22C-A79B06BB7981Q24746249-779B68D5-8B20-4822-9281-56BACBD9332BQ24805207-3479823A-2925-4C59-A8A6-328D36DB38EEQ27309998-B9CEDEDA-0DC2-4889-AD75-010E85268D8DQ27319440-2C49405F-69C5-4A1D-8232-904461510FD1Q28140037-CABE5D10-2504-418C-B845-C0CCD068E25BQ28144756-E96AC0AF-6FC6-40D0-9719-7BC5A58AE10CQ28191639-3AEF9ED1-2C14-4719-AAE6-03B41847DDDDQ28205058-40180FBC-98E2-4E22-AB6F-C4C6946791E3Q28207963-867F1781-7659-4CDB-A7A5-71D1EE3B93B4Q28474456-82267228-9C72-48A1-BCF6-BB420CEC0FA4Q28477345-0BEAB3AD-4EB5-4963-A2DB-E15DCD5F803DQ30168103-F21D2F99-3B22-4416-9C35-4D7E1F478A09Q30480366-AF01D70B-6ABD-4A90-91B2-63A3050CA9EFQ30661625-DAC438BC-598C-4C4E-A6C2-6FF03FEBDEBDQ31085503-FDC96748-47F8-4E54-BDF6-9C51F970B823Q33288820-325F76AB-F10C-4970-8C59-EDBCC9899054Q33779499-BDA924A8-12B2-499E-914A-2626A6A6D5FEQ34243592-071BFCA5-C2DA-439B-9D3C-BE876874C5A3Q34481586-3DBD59BA-24B0-43AA-8463-2A7F82CEE1E9Q34557771-80EC892E-3D4A-4342-BD56-8D82625C30D7Q34743655-91CF3975-AE0C-4A81-BA3C-F24411672552Q34959208-95FA0687-DD0A-4E0E-8F89-FEB30CB06F88Q35001515-8AB0FB5A-4ACA-495D-B741-C91768B13334Q35164627-784C9BCD-6139-4340-B2DE-393FECE16E6DQ35264323-0E6DC8D7-F1F3-4259-BD49-96EE0C7C928AQ35301664-B853BD34-5A6F-4F83-8EDD-7DE7D2ADF358Q35553879-63609274-298D-4368-8698-DD8F5313101BQ36743790-62F0510F-F9C9-432B-92C8-0F8A44A13967Q36879620-997B11CE-11B4-47E1-8A22-2809D9CBE4AFQ36945939-87518984-42F3-4BC9-BD54-91ECC701CCD9Q36956729-A6D81F91-4E29-45E8-9ABD-1DE21D1E85B9Q37232874-7C5B0657-D999-4C75-A88A-9D286E51E0CBQ37233499-21259408-CB49-4213-8397-971D078534CCQ37699758-33AE7419-43DD-413F-AFE1-42716144D712Q37847052-77120428-CF61-40E9-B8FA-B1A4047664DE
P2860
Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activation.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Etk, a Btk family tyrosine kin ...... inking Src to STAT3 activation
@nl
Etk, a Btk family tyrosine kin ...... nking Src to STAT3 activation.
@ast
Etk, a Btk family tyrosine kin ...... nking Src to STAT3 activation.
@en
Etk, a Btk family tyrosine kin ...... nking Src to STAT3 activation.
@en-gb
type
label
Etk, a Btk family tyrosine kin ...... inking Src to STAT3 activation
@nl
Etk, a Btk family tyrosine kin ...... nking Src to STAT3 activation.
@ast
Etk, a Btk family tyrosine kin ...... nking Src to STAT3 activation.
@en
Etk, a Btk family tyrosine kin ...... nking Src to STAT3 activation.
@en-gb
prefLabel
Etk, a Btk family tyrosine kin ...... inking Src to STAT3 activation
@nl
Etk, a Btk family tyrosine kin ...... nking Src to STAT3 activation.
@ast
Etk, a Btk family tyrosine kin ...... nking Src to STAT3 activation.
@en
Etk, a Btk family tyrosine kin ...... nking Src to STAT3 activation.
@en-gb
P2093
P2860
P1476
Etk, a Btk family tyrosine kin ...... nking Src to STAT3 activation.
@en
P2093
P2860
P304
P356
10.1128/MCB.20.6.2043-2054.2000
P407
P577
2000-03-01T00:00:00Z